Ahead of Kamada (KMDA) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Kamada stock sets November 9 date for third-quarter results

An 8:30 a.m. ET call will follow Kamada (KMDA) earnings on November 9, 2026.

Kamada to Announce Third Quarter and Nine Months Ended September 30, 2026, Financial Results on November 9, 2026

At 8:30 a.m. ET on Nov. 9, investors can question Kamada's management live.

Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026

Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel

Kamada Expands Biosimilar Portfolio With Commercial Launch Of Two Additional New Products In Israel, Adding To Existing Portfolio Of Two Products

Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth

CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand

Insider Sale: Director at $KMDA Sells 162,760 Shares

Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders

Is Kamada (KMDA) a Solid Growth Stock? 3 Reasons to Think "Yes"

Should Value Investors Buy Kamada (KMDA) Stock?